Sanofi Buys Out Arixtra Joint Venture With Organon; Expanded Label Coming

Sanofi-Synthelabo is taking over sole rights to Arixtra from Organon ahead of an expected label expansion for the antithrombotic agent

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet